0001209191-19-024303.txt : 20190410 0001209191-19-024303.hdr.sgml : 20190410 20190410175222 ACCESSION NUMBER: 0001209191-19-024303 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190407 FILED AS OF DATE: 20190410 DATE AS OF CHANGE: 20190410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LASEZKAY GEORGE M CENTRAL INDEX KEY: 0001020514 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 19742447 MAIL ADDRESS: STREET 1: 1301 SECOND AVE., SUITE 4200 CITY: SEATTLE STATE: WA ZIP: 98101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452437375 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: 2Q ZIP: 30005 BUSINESS PHONE: 678-270-3631 MAIL ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: 2Q ZIP: 30005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-07 0 0001539029 Clearside Biomedical, Inc. CLSD 0001020514 LASEZKAY GEORGE M C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005 1 1 0 0 Interim CEO Stock Option (right to buy) 1.40 2019-04-07 4 A 0 250000 0.00 A 2029-04-06 Common Stock 250000 250000 D The shares underlying this option vest in six equal monthly installments beginning on May 7, 2019. /s/ Mark Ballantyne, Attorney-in-Fact 2019-04-10